Gene Patenting: Days Numbered?

Man I hope so.

By declaring that the genes can’t be patented because they are essentially products of nature rather than inventions, the US District Court for the Southern District of New York state has effectively cast doubt on whether patents on 2000 other human genes – around 20 per cent of the total – are valid, The Times of London reports.

More Here.

I have been influenced by some podcasts I’ve heard (try this and this and this and this and this) on patents.

I think the system sucks.

Profile of a Scareware Company

“Not everyone was happy about it, but money is money,” the translator says. IM was paying around 60 per cent more than similar jobs elsewhere offered.

A mid-level employee, who left three years ago after realising what the company was doing, says that initially IM employed skilled developers to create genuine products. As managers became increasingly concerned with making money, quality declined and the fake scans came into use.

more here:

Cat Bonds Need to Expand?

Here’s the upshot:

Among the ideas suggested for market expansion are expanding the lines of business covered to include risks such as workers compensation and liability risks and also allowing cat bonds to address broader geographical coverage rather than peril and location specific risks.

Is this cheap talk? We definitely get a lot of that in the (re) insurance business. It’s a mega competitive market and the only real way of innovating is by introducing new information that gives you an edge in evaluating risk.

AND THEN you need to be proven right in your risk evaluation, which can often take years, perhaps take too long, actually, for you to make any money on it.

What investors are saying is: give us the information we need to evaluate new risks. Well, shucks, wouldn’t we all like that…